期刊文献+

畜禽疫苗佐剂研究进展 被引量:2

Recent Progress in Veterinary Vaccine Adjuvant
下载PDF
导出
摘要 畜禽用疫苗主要是亚单位疫苗、减毒或灭活细菌/病毒疫苗,为了使疫苗对动物能达到长效持久的保护,必须使用有效的佐剂。根据不同的作用方式,目前可将佐剂主要分为2大类:疫苗传递系统的佐剂、免疫刺激作用佐剂。本文探讨了近年来畜禽用疫苗佐剂的功能及其发展趋势,概述了其应用研究的进展。 The veterinary vaccine mainly comprise of either subunit, live attenuated or inactivater bacteria/viruses. These vaccines would require optimal adjuvants and delivery systems to accord long-term protection from infectious diseases in animals. Adjuvants can be broadly divided into two classes, based on their principal mechanisms of action:vaccine delivery systems and immunostimulatory adjuvants. The function and development of adjuvant in animals were dicussed here, and the recent progress in application was also included.
出处 《生物技术通讯》 CAS 2005年第2期231-233,共3页 Letters in Biotechnology
基金 广州市科技攻关重点项目(2003Z2-E0221) 广东省农业攻关项目(2003B21403)
关键词 畜禽疫苗佐剂 免疫刺激剂 疫苗传递系统 乳化 功能 发展趋势 veterinary vaccine adjuvants immunostimulator vaccine delivery systems emulsion
  • 相关文献

参考文献28

  • 1陆军,严维耀,郑兆鑫.基因疫苗——防治疾病的新武器[J].生命的化学,2000,20(1):17-19. 被引量:12
  • 2李祥瑞,赵星灿,张江宏,李金凤,怀川,周建国,姚延峰.重组白细胞介素-2用于猪链球菌病治疗试验[J].畜牧与兽医,2002,34(2):26-26. 被引量:12
  • 3武梅,高荣,李江凌,孟明杰,龙章富,唐漫书,殷雪,沈翼,王丽焕,巫雪艳,谢鸿观,刘世贵.CpG序列及阳离子脂质体对猪带绦虫抗原基因免疫应答的影响[J].高技术通讯,2002,12(7):39-41. 被引量:6
  • 4Aucouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines[J]. Vaccine, 2001,19:2666.
  • 5Aucouturier J, Ganne V, Laval A. Efficacy and safety of new adjuvants[j]. Ann. NY Acad Sci, 2000,916:600.
  • 6Bowerstock L, Martin S. Vaccine delivery to animals[J]. Adv Drug Deliv Rev, 1999,167.
  • 7Gupta RK. Adjuvant-a balance between toxicity and adjuvoontility [J]. Vaccine, 1993,11(3):293.
  • 8Krieg, AM. CpG motifs in bacterial DNA and their immune effects [J]. Immunol, 2002,20:709.
  • 9Krieg AM, Yi AK. CpG motifs in bacterial DNA trigger direct Bcell activation[J]. Nature, 1995,374:546.
  • 10Yi AK, Klinman DM, Martin TL, et al. Rapid immune activation by CpG motifs in bacterial DNA, Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway[J]. J Immunol, 1996,157:5394.

二级参考文献38

  • 1曹雪涛,章卫平,顾申,陶群,周正芳,郑玲莉,叶天星.成纤维细胞介导的人白介素6基因疗法增强机体免疫功能的实验研究[J].中国免疫学杂志,1994,10(1):8-12. 被引量:26
  • 2Sambrook J Fritsch E F.分子克隆实验指南(第二版)[M].北京:科学出版社,1992..
  • 3杨贵贞.免疫学新进展专题讲座[M].长春:白求恩医科大学出版社,1987,200..
  • 4[1]Beard C W, Mason P W. Nature Biotechnology, 1998, 16(12): 1325
  • 5[2]O'Hagan D T. Journal of Pharmacy and Pharmacology, 1998, 50: 1
  • 6[3]O'Hagan D T, Mackichan M L, Singh M. Biomol Eng, 2001, 18(3): 69
  • 7[4]Krieg A M, Yi A K, Matson S, et al. Nature, 1995, 374(6522): 546
  • 8[5]Sato Y, Roman M, Tighe H, et al. Science, 1996, 273: 352
  • 9[6]Gurselt G G, Gursel M, McCormack B. J Contr Rel, 1996, 41: 49
  • 10[7]Felgner P L, Gadek T R, Holm M, et al. Pro Natl Acad Sci USA, 1987, 84(11): 7413

共引文献47

同被引文献24

  • 1胡北侠,黄艳艳,任素芳,黄庆华,吴加强,颜世敢.兽医常用免疫佐剂的研究概况与发展趋势[J].中国畜牧兽医,2005,32(3):38-40. 被引量:9
  • 2郭慧琛,孙世琪,刘在新.佐剂及其在基因免疫研究中的应用[J].中国兽医科技,2005,35(4):315-321. 被引量:1
  • 3秦玉明,赵耘,李宇,王栋.国外疫苗佐剂的评价[J].中国兽药杂志,2005,39(6):34-37. 被引量:8
  • 4Schijns V. Immunological concepts of vaccine adjuvant activity[J]. Curr Opin Immunol, 9.000,19:9321-2328.
  • 5Eugene M A, Hattie L G, Luuk A T, et al. Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant [J]. J Virol, 8002,76 (20):10540-10545.
  • 6Avi-Hai H, Yolanta F, Herve B. Gamma interferon and monophosphoryl lipid A-Trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellularvaccine[J]. Inf and Imm,2005,73(1):250-257.
  • 7Dittmann S. Vaccine safety: risk communication a global perspectives [J]. Vaccine, 2001, 19:2446.
  • 8Gluck R, Mischler R, Durrer P, et al. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Eacherichia coli heat-labile toxin as a mucosal adjuvant[J]. J Infect Dis, 2000,181:1129-1132.
  • 9Dan F, Ruth M, David S B, et al. Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears amyloid in a mouse model of Alzheimer dlsease[J]. J Clin Invest,2005, 10:1172-1179.
  • 10Jaceed A S, Patricia A D, David R A, et al. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotidesto act as an adjuvant for protective vaccine immunity against Ltishmania major in mice[J]. J Exp Med , 2003,198(2):281-291,

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部